Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
05/2000
05/30/2000US6068984 Separating hb15 prositive cells from population of unrelated cells by reacting antibody that specifically binds the extracellular, transmembrane or cytoplasmic domain of the glycoprotein, then isolating cells
05/30/2000US6068983 Introducing into cells a dna molecule coding for an fc receptor which is then expressed for increased phagocytic activity; combating infection and/or modulating immune complex disease
05/30/2000US6068818 Electronic device for performing active biological operations; and methods for manufacture of such devices containing active electrodes especially adapted for electrophoretic transport of nucleic acids, their hybridization and analysis
05/25/2000WO2000029561A2 Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope
05/25/2000WO2000029444A1 Generation of antibodies using polynucleotide vaccination in avian species
05/25/2000WO2000029424A1 Polymorphic human pc-1 sequences associated with insulin resistance
05/25/2000WO2000029420A2 Methods of making modified nucleosides
05/25/2000WO2000003039A9 Methods for determining cross-hybridization
05/25/2000CA2369119A1 Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope
05/25/2000CA2350139A1 Methods of making modified nucleosides
05/25/2000CA2350111A1 Generation of antibodies using polynucleotide vaccination in avian species
05/24/2000EP1002860A1 Method for purification and manipulation of nucleic acids using paramagnetic particles
05/24/2000EP1002137A1 Denaturing multi ion polynucleotide chromatography for detecting mutations
05/24/2000EP1002077A1 Secreted proteins encoded by human chromosome 13
05/24/2000EP1001996A1 Complex chemical compound, synthesis and various applications of said compound
05/24/2000EP1001786A1 Method of treating rhinoviral infections
05/24/2000CN1052728C Method for extracting full gene group DNA of giant panda
05/23/2000US6066722 Nucleoside analogues used as antiprotozoal agents especially against plasmodium
05/23/2000US6066720 Modified oligonucleotides, their preparation and their use
05/23/2000US6066625 Enzyme inhibitor; modulators of gene expression
05/23/2000US6066624 Gene therapy for solid tumors using adenoviral vectors comprising suicide genes and cytokine genes
05/23/2000US6066503 Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
05/23/2000US6066502 Endothelin converting enzyme (ECE)
05/23/2000US6066485 Fibroblast growth factor activated enzyme isolated from germ cells of testes; antiproliferative/anticarcinogenic/antitumor agents; diagnosis of related diseases
05/23/2000US6066484 Enzyme which decomposes nucleosides to free bases and ribose; for reducing purine levels of foods, including beer, to prevent gout and hyperuricemia
05/23/2000US6066447 Including nucleoside dimers with modified backbones; for viricides and antisense agents
05/23/2000US6066356 Genetic engineering; animal feeds; foods
05/23/2000US6066317 Method of using IL-11 for treating deficiencies in hematopoietic progenitor or stem cells
05/23/2000CA2079448C Lanthanide chelate-conjugated oligonucleotides
05/23/2000CA2019939C Hydrophobic nucleic acid probe
05/23/2000CA2006818C Insulin derivatives, a process for the preparation thereof, the use thereof and a pharmaceutical formulation containing them
05/18/2000WO2000028089A1 Functionalized nanocrystals and their use in labeling for strand synthesis or sequence determination
05/18/2000WO2000028088A1 Nanocrystals having polynucleotide strands and their use to form dendrimers in a signal amplification system
05/18/2000WO2000028087A1 A library of modified primers for nucleic acid sequencing, and method of use thereof
05/18/2000WO2000027864A1 CHROMOSOME 17p-LINKED PROSTATE CANCER SUSCEPTIBILITY GENE
05/18/2000WO2000027860A2 Polynucleotide crosslinking agents
05/18/2000WO2000027859A1 Improved processes for the synthesis of oligomeric compounds
05/18/2000WO2000027521A1 A method for reproducing molecular arrays
05/18/2000WO2000012756A3 Reaction chambers coated with defined concentrations of nucleic acids, method for the production and use thereof
05/18/2000WO2000009738A9 Rolling circle-based analysis of polynucleotide sequence
05/18/2000WO2000009672A9 Dnazymes and methods for treating restenosis
05/18/2000WO2000009525A3 Low adenosine anti-sense oligonucleotide agent, composition, kit and treatments
05/18/2000WO2000008141A3 Short oligonucleotides for the inhibition of vegf expression
05/18/2000WO2000008140A3 Antisense oligonucleotides for the inhibition of vegf expression
05/18/2000WO1999024470A8 Mammalian milk growth factor
05/18/2000DE19940749A1 Integrated synthesis and analysis method e.g. for polymers, comprises a carrier body provided with immobilized receptors to provide respective channels before contact with sample and subsequent analysis
05/18/2000CA2350087A1 Chromosome 17p-linked prostate cancer susceptibility gene
05/18/2000CA2348821A1 Polynucleotide crosslinking agents
05/18/2000CA2348696A1 A method for reproducing molecular arrays
05/17/2000EP1001026A2 Riboflavinoverproducing strains of bacteria
05/17/2000EP1000176A1 Computer method and system for correlating sequencing data by ms
05/17/2000EP1000083A1 Oxidized styrenic polymers for dna binding
05/17/2000EP1000081A2 A reversible stoichiometric process for conjugating biomolecules
05/17/2000EP1000042A1 Fluorescent dibenzazole derivatives and methods related thereto
05/17/2000EP0773950A4 Linked peptide nucleic acids
05/17/2000EP0721458B1 Biopolymer synthesis utilizing surface activated, organic polymers
05/17/2000EP0694079B1 Enzymatic ligation of 3'-amino-substituted olignucleotides
05/17/2000CN1253180A Specific protein of human neuroendocrine, coding sequence and its preparating process and application
05/17/2000CN1253138A Structure and usage of antisense oligonucleotide for treating diseases correlative to hepatitis C virus
05/17/2000CN1052510C Mammalian receptors for interleukin-10
05/16/2000US6063766 Drugs and proteins from blood with amino acid sequences
05/16/2000US6063623 Transport protein which effects the transport of cationic xenobiotics and/or pharmaceuticals, DNA sequences encoding it and their use
05/16/2000US6063608 Cloned genes encoding reverse transcriptase lacking RNase H activity
05/16/2000US6063603 Kit for simple and efficient isothermal accumulation of preferential nucleotide sequences
05/16/2000US6063601 Chimaeric gene coding for a transit peptide and a heterologous peptide
05/16/2000US6063595 Method of forming a macromolecular microgene polymer
05/16/2000US6063574 Dioxetane labeled probes and detection assays employing the same
05/16/2000US6063569 Methods for automated synthesis of PNA-DNA chimeras and compositions thereof
05/16/2000US6063566 Enzymatic ribonucleic acid molecule which catalyzes the position preferential cleavage of single-stranded deoxyribonucleic
05/16/2000US6063565 Double receptor polynucleotide assay method
05/16/2000CA2098201C Methods, kits and reactive supports for 3' labeling of oligonucleotides
05/16/2000CA1340992C Process for the production of recombinant porcine growth hormone polypeptides
05/11/2000WO2000026416A1 Reference clones and sequences for non-subtype b isolates of human immunodeficiency virus type 1
05/11/2000WO2000026411A1 Method for making complementary oligonucleotide tag sets
05/11/2000WO2000026396A1 A method of recombination and agents useful for same
05/11/2000WO2000026368A2 Therapeutic antiangiogenic endostatin compositions
05/11/2000WO2000026343A2 Tissue specific promoters and transgenic animals for the screening of pharmaceuticals
05/11/2000WO2000026226A1 Multidomain polynucleotide molecular sensors
05/11/2000WO2000025936A1 Method for controlled electrostatic adherent deposition of particles on a substrate
05/11/2000DE19940810A1 Biochemical analysis instrument uses mixture of sample and smart reagent beads viewed by color CCD camera to perform chemical analysis of medical samples.
05/11/2000CA2349836A1 Method for making complementary oligonucleotide tag sets
05/11/2000CA2348779A1 Multidomain polynucleotide molecular sensors
05/11/2000CA2348774A1 Therapeutic antiangiogenic endostatin compositions
05/10/2000EP0999271A2 Retinoid receptor compositions and methods
05/10/2000EP0998582A1 Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells
05/10/2000CN1252449A New human gene code sequence, encoded polypeptide and preparation
05/10/2000CN1252448A Human actin related protein gene and encoded polypeptide and preparation and application
05/10/2000CN1252447A New human gene sequence and encoded polypeptide and the preparation
05/10/2000CN1252446A New human gene sequence and encoded polypeptide and the preparation and application
05/10/2000CN1252445A Whole genome sequence of YN87448 virus strain and its cloning method
05/10/2000CN1252444A Whole genome sequence of Syndebis virus strain and its cloning method
05/09/2000US6060596 Encoded combinatorial chemical libraries
05/09/2000US6060595 Inhibition of viral replication
05/09/2000US6060592 Pyrimidine nucleoside compounds and oligonucleoside compounds containing same
05/09/2000US6060587 Cellular receptor for HIV-1 VPR essential for G2/M phase transition of the cell cycle
05/09/2000US6060458 Oligodeoxyribonucleotides comprising O6 -benzylguanine and their use
05/09/2000US6060456 Chimeric oligonucleoside compounds
05/09/2000US6060284 Polynucleotide coding for antigenic polypeptides of specific amino acid sequences; for diagnosis and therapy of immune and autoimmune disorders; polymerase chain reaction primers; hybridization probes
05/09/2000US6060273 Multicistronic expression units and their use
05/09/2000US6060064 Chimeric virus-like particle antigen presentation and delivery system